Evaluation of the LITE-Risk Prognostic Model in Consolidation Durvalumab and Osimertinib-Treated NSCLC A. Gibson, M. Dean, D. Y. Heng,D. E. Meyers, Y. Ruan, R. Sangha,I. Stukalin, W. Y. Cheung,V. NavaniJournal of Thoracic Oncology（2023）引用 0|浏览0暂无评分关键词prognostic score,real-world outcomes,advanced NSCLCAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
